RxDoctor Payments Data

Craig Brady, DO

Family Medicine · Show Low, AZNPI 1447224548

Payments from drug & device makers

$285in general payments, 2019–2025

Across 16 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$55
  • Novo Nordisk$48
  • Novartis$45
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$27
  • Dexcom, Inc.$25
  • Pfizer$16
  • plus $68 from 5 others

What the payments were for

  • Speaking & faculty fees$124%
  • Food & beverage$27296%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$285 in reported general payments places this provider in the 50th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$144,468
Medicare patients
251
Services billed
2,241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$138,436
OzempicSemaglutide47$65,902
JardianceEmpagliflozin59$64,651
RybelsusSemaglutide25$21,991
ProliaDenosumab11$18,740
BriviactBrivaracetam12$17,854
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro29$17,697
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$12,214
Combivent RespimatIpratropium/Albuterol Sulfate20$11,193
XareltoRivaroxaban14$9,923
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp20$7,037
SymbicortBudesonide/Formoterol Fumarate23$6,822
Novolog FlexpenInsulin Aspart12$4,735
Albuterol Sulfate HfaAlbuterol Sulfate148$4,682
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$3,724

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$16$140,673111 claims
Novo NordiskOzempic, Rybelsus$48$87,89372 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Show Low

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →